Artificial chimeric exosomes for anti-phagocytosis and targeted cancer therapy
, alongside large-scale standardized preparation, stable structure, high drug-loading capacity and custom-tailored functionality, highlighting the suitability of ACEs as promising alternatives of exosomes in clinical applications.
